• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Researchers develop responsive, insulin-releasing skin patch

January 19, 2017 By Sarah Faulkner

Researchers develop responsive, insulin-releasing skin patch Researchers from the University of North Carolina at Chapel Hill, North Carolina State University and Changchun Institute of Applied Chemistry at the Chinese Academy of Sciences have developed a skin patch that measures blood glucose levels and releases insulin when levels climb too high. The team’s work testing the patch in mice was published earlier this month in ACS Nano.

People suffering with Type I diabetes don’t make insulin, while those with Type II can’t use insulin effectively. Both groups of patients are tasked with monitoring their blood sugar regularly using finger prick tests. Some patients inject themselves with insulin when their blood sugar fall to dangerous levels. But, even if a patient is closely monitoring their readings, their blood glucose levels can get out of control.

The collaborative team of researchers were hoping to develop a device that could manage diabetes in a simpler, more effective way.

The team’s skin patch is made up of biodegradable microneedles filled with tiny, insulin-carrying pouches that are engineered to break apart and release insulin in response to high glucose levels. The microneedles are made using a polymer that is loaded with glucose oxidase. When the glucose oxidase reacts with glucose, hydrogen peroxide forms and the needles disintegrate, releasing insulin into the bloodstream.

Mice with diabetes wearing the skin patch maintained level concentrations of insulin their blood. When the researchers administered a shot of glucose to the mice, their blood sugar levels spiked and then fell to normal levels within 2 hours.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Research & Development Tagged With: Chinese Academy of Sciences, North Carolina State University, University of North Carolina at Chapel Hill

IN CASE YOU MISSED IT

  • MiniMed completes split from Medtronic
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS